Assertio Holdings (ASRT) Operating Expenses (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Operating Expenses came in at $28.4 million in Q1 2026, down 28.49% year-on-year from $39.7 million in Q1 2025, and up 12.3% quarter-over-quarter from $25.3 million in Q4 2025.
Assertio Holdings (ASRT) Operating Expenses (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Operating Expenses across 8 years of filings, most recently posting $28.4 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $28.4 million, down 28.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.5 million (down 37.34% YoY), and the FY2025 annual result was $140.2 million, down 6.15% from the prior year.
- Operating Expenses came in at $28.4 million for Q1 2026 at Assertio Holdings, up from $25.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $263.9 million in Q3 2023 to a low of $3.8 million in Q2 2025.
- The 5-year median for Operating Expenses is $34.7 million (2024), against an average of $46.9 million.
- Across the five-year window, Operating Expenses surged 850.03% in 2023 and tumbled 89.06% in 2025, its largest moves.
- Assertio Holdings' Operating Expenses stood at $39.7 million in 2022, then soared by 64.4% to $65.3 million in 2023, then slumped by 30.1% to $45.7 million in 2024, then plunged by 44.61% to $25.3 million in 2025, then increased by 12.3% to $28.4 million in 2026.
- The last three Operating Expenses figures came in at $28.4 million (Q1 2026), $25.3 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | 28.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.40 Mn |
| Dec 31, 2025 | 25.29 Mn |
| Sep 30, 2025 | 37.98 Mn |
| Jun 30, 2025 | 3.80 Mn |
| Mar 31, 2025 | 39.72 Mn |
| Dec 31, 2024 | 45.66 Mn |
| Sep 30, 2024 | 32.25 Mn |
| Jun 30, 2024 | 34.74 Mn |
| Mar 31, 2024 | 36.79 Mn |
| Dec 31, 2023 | 65.31 Mn |
| Sep 30, 2023 | 263.90 Mn |
| Jun 30, 2023 | 28.57 Mn |
| Mar 31, 2023 | 37.82 Mn |
| Dec 31, 2022 | 39.73 Mn |
| Sep 30, 2022 | 27.78 Mn |
| Jun 30, 2022 | 24.34 Mn |
| Mar 31, 2022 | 24.98 Mn |
| Dec 31, 2021 | 25.35 Mn |
| Sep 30, 2021 | 19.54 Mn |
| Jun 30, 2021 | 37.37 Mn |